The
#AIEye: Amazon (Nasdaq: $AMZN) Teams with 30 Leading Tech Firms to Announce
Voice Interoperability Initiative and Watson Health (NYSE: $IBM) Signs
Agreement with Guerbet for #AI Prostate Cancer Solution
Global
#AI-Enabled Medical Imaging Market to See 30.95% CAGR from 2019-2029
Point Roberts WA, Vancouver BC – September 24,
2019 – Investorideas.com (www.investorideas.com), a global investor news source covering
Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal
tracker and advancements in artificial intelligence.
Listen
to today’s podcast:
Read
this in full at https://www.investorideas.com/news/2019/artificial-intelligence/09241AIEye-AMZN-IBM.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (NasdaqGS:AMZN) (NYSE:IBM) (OTC:GUERF)
Amazon (NasdaqGS:AMZN), along with several other leading
tech companies, has announced the Voice Interoperability
Initiative, a new program designed to ensure that voice services will work
seamlessly alongside one another on a single device, and that voice-enabled
products should be designed to support multiple simultaneous wake words. More
than 30 companies are supporting the project, which lists as its chief aims:
●
Developing
voice services that can work seamlessly with others, while protecting the
privacy and security of customers
●
Building
voice-enabled devices that promote choice and flexibility through multiple,
simultaneous wake words
●
Releasing
technologies and solutions that make it easier to integrate multiple voice
services on a single product
●
Accelerating
machine learning and conversational AI research to improve the breadth, quality
and interoperability of voice services
Amazon founder and CEO Jeff Bezos commented:
“Multiple
simultaneous wake words provide the best option for customers. Utterance by
utterance, customers can choose which voice service will best support a
particular interaction. It’s exciting to see these companies come together in
pursuit of that vision.”
Watson Health, a unit of IBM (NYSE:IBM), has signed an agreement with medical imaging contrast agents
manufacturer Guerbet (OTC:GUERF) to co-develop and co-commercialize
an artificial intelligence (AI) solution to help clinicians diagnose and
monitor patients with prostate cancer. David Gruen, M.D., Chief Medical
Officer, Imaging, IBM Watson Health, explained:
"The
main diagnostic challenge with prostate cancer lies in identifying cancers
requiring rapid treatment and those requiring only active surveillance, while
avoiding unnecessary biopsies. For this reason, optimal patient outcomes depend
on the rapid and accurate diagnosis and treatments that AI technologies can
potentially help provide."
Global
AI-Enabled Medical Imaging Market to See 30.95% CAGR from 2019-2029
A report from Research and Markets finds that the global
AI-enabled Medical Imaging market, which generated revenue of $404 million USD
in 2018, will see a compound annual growth rate (CAGR) of 30.95 percent in the
forecast period 2019 to 2029. An excerpt from the report description reads:
The
market growth in the global AI-enabled medical imaging solutions market can
primarily be attributed to the factors such as expanding the range of
applications of AI, shortage of healthcare workforce, and huge R&D
investments as well as fundings. However, there are significant challenges
which are restraining the market growth. These challenges include privacy and
security concerns related to healthcare data and barriers to physician’s
adoption of AI.
Sam Mowers,
Investorideas.com
For
a list of artificial intelligence stocks on Investorideas.com visit here
or become an Investor Ideas member
About Investorideas.com - News that
Inspires Big Investing Ideas Investorideas.com is a
recognized news source publishing third party news and press releases plus we
create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock news column, Investor
Ideas #Potcasts #Cannabis News and Stocks on the Move
podcast and column, Cleantech and
Climate Change Podcast and the AI Eye Podcast and column covering
developments in AI.
The Investorideas.com podcasts are
also available on iTunes, Spotify,
Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit
the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more
about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock
news, deal tracker and advancements in artificial intelligence is an
original content brand of Investorideas.com
Contact
Investorideas.com
800 665 0411
No comments:
Post a Comment